Prospective study effect of leukotriene receptor antagonist add on therapy in asthma : pilot study

Phase 4

Recruiting

• Conditions: exacerbation; Short acting inhaled bronchodilator will be permitted through out the trial.; Asthma; lung function

• Registration Number: TCTR20200408006
• Lead Sponsor: Faculty of medicine CM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-08
• Study Completion: 2021-03-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Clinical diagnosed asthma
age >= 18 year
Treated with low to moderate dose of ICS/LABA
Not well control asthma (ACT score < 20 or physician diagnosed as not well controlled asthma

Exclusion Criteria

History of severe exacerbation including hospitalization / ER visit in the precious year.
Pregnancy or child bearing.
Subjects who were treated with systemic steroid in the previous 6 months.
Subjects who were treated with LAMA.
Subjects who were treated with montelukast in the last 3 months.
age >= 80 years

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
acute exarcerbation of asthma 12 months time per year

Secondary Outcome Measures

Name	Time	Method
ACT score 12 months point every 3 months,PFT parameter 12 months point every 3 months